Liquid Biopsy Market Scope And Analysis

Report Code : TIPRE00003996
Category : Life Sciences

No. of Pages : 150

Buy Now

Liquid Biopsy Market Analysis, Scope, and Growth by 2031

Buy Now

Liquid Biopsy Market Report Scope

Report Attribute	Details
Market size in 2021	US$ 4.57 Billion
Market Size by 2031	US$ 12.69 Million
Global CAGR (2023 - 2031)	11.2%
Historical Data	2021-2022
Forecast period	2023-2031
Segments Covered	By Product & Services Equipment Reagents & Kits Services By Sample Blood Based Urine Based Other samples By Circulating Biomarker Circulating Tumor Cells Exosomes Free Nucleic Acid By Application Noninvasive Prenatal Testing Oncology Transplant Diagnostics Other Applications
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Biocept inc Bio rad laboratories inc Lunglife ai inc exosome diagnostics F Hoffmann la roche ltd Inivata ltd Exact sciences corporation Mdxhealth Qiagen Thermo fisher scientific inc

Liquid Biopsy Market News and Recent Developments

The Liquid Biopsy Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for liquid biopsy:

In February 2024, Twist Bioscience Corporation launched the cfDNA Library Preparation Kit to facilitate liquid biopsy research using its silicon platform. (Source: Twist Bioscience Corporation, 2024)
In September 2023, Pillar Biosciences, a provider in decision medicine, globally launched oncoReveal Core LBx, a next-generation sequencing (NGS) kit designed to enable laboratories with a solution for liquid biopsy-based pan-cancer tumor profiling. (Source: Pillar Biosciences, 2023)
In July 2022, BillionToOne, Inc., a next-generation molecular diagnostics company, launched its first oncology liquid biopsy products - Northstar Select and Northstar Response. These products are currently available for research use with select academic cancer centers. (Source: BillionToOne, Inc., 2022)

Liquid Biopsy Market Report Coverage and Deliverables

The “Liquid Biopsy Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Market dynamics such as drivers, restraints, and key opportunities
Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis
Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
Detailed company profiles